Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis
Dong-Yun Lee, Hyang Gi Park, Byung-Koo Yoon, DooSeok Choi
Obstet Gynecol Sci. 2016;59(1):32-38.   Published online 2016 Jan 15     DOI: https://doi.org/10.5468/ogs.2016.59.1.32
Citations to this article as recorded by Crossref logo
The effect of surgery or medication on pain and quality of life in women with endometrioma. A systematic review and meta-analysis
A. Keukens, V.B. Veth, M. Regis, V. Mijatovic, M.Y. Bongers, S.F.P.J. Coppus, J.W.M. Maas
European Journal of Obstetrics & Gynecology and Reproductive Biology.2024; 293: 95.     CrossRef
Actualización sobre las posibilidades de tratamiento médico hormonal para el sangrado menstrual abundante
J. Estadella Tarriel, J. Perelló Capó, R. Muñoz Sánchez
Clínica e Investigación en Ginecología y Obstetricia.2023; 50(1): 100819.     CrossRef
Medical treatments of endometriosis: a review
Bahi Elbasueny, Maya Geerts, Emily C. Yang, Catherine Allaire, Paul J. Yong, Mohamed A. Bedaiwy
Reproductive and Developmental Medicine.2023; 7(3): 166.     CrossRef
Terapias emergentes en el tratamiento médico de los miomas uterinos
Mikel Goitia, Josep Estadella
Medicina Clínica.2023; 161: S32.     CrossRef
Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids
Mohamed Ali, Mohamed Raslan, Michał Ciebiera, Kornelia Zaręba, Ayman Al-Hendy
Expert Opinion on Drug Safety.2022; 21(4): 477.     CrossRef
Efficacy of ulipristal acetate (UPA) for the treatment of expulsion uterine myomas: report of two cases
Innocenza Palaia, Valentina Del Negro, Alice Fracassi, Michele Schiavi, Violante Di Donato, Margherita Fischetti, Ludovico Muzii, Pierluigi Benedetti Panici
Gynecological Endocrinology.2020; 36(7): 660.     CrossRef
Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis
Luigi Della Corte, Fabio Barra, Antonio Mercorio, Giulio Evangelisti, Agnese Maria Chiara Rapisarda, Simone Ferrero, Giuseppe Bifulco, Pierluigi Giampaolino
Expert Opinion on Drug Metabolism & Toxicology.2020; 16(9): 759.     CrossRef
Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review
Jacques Donnez
Journal of Clinical Medicine.2020; 9(12): 3948.     CrossRef
Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture
May-Tal Sauerbrun-Cutler, Ruben Alvero
Fertility and Sterility.2019; 112(5): 799.     CrossRef
Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study
Thomas D’Hooghe, Takao Fukaya, Yutaka Osuga, Robin Besuyen, Beatriz López, Gertjan M Holtkamp, Kentaro Miyazaki, Laurence Skillern
Human Reproduction.2019; 34(5): 813.     CrossRef
Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis)
C. Azoulay, C. Bardy, M. Lasserre, J.-L. Brun
EMC - Ginecología-Obstetricia.2018; 54(1): 1.     CrossRef
Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice
Thomas Römer
Archives of Gynecology and Obstetrics.2018; 298(4): 747.     CrossRef
Management of Chronic Pelvic Pain
LAUREN A. BISHOP
Clinical Obstetrics & Gynecology.2017; 60(3): 524.     CrossRef